Sex Hormone Testing

Comprehensive Sex Hormone Testing: High-Sensitivity Mass Spectrometry and Dynamic Profiling for Reproductive Endocrinology, Menopause Management, and Andrology

Sex hormone testing is a cornerstone of reproductive medicine, endocrinology, and general health assessment, with profound implications for fertility, pubertal development, menstrual disorders, androgen deficiency, menopause transition, and hormone-sensitive malignancies. However, conventional immunoassays for oestradiol, testosterone, progesterone, and gonadotrophins often suffer from cross-reactivity, poor sensitivity at low concentrations, and inadequate specificity in paediatric, female, and elderly populations. Clinicians and researchers increasingly seek a testing service that goes beyond static single-point measurements to provide a dynamic, individualised, and analytically rigorous characterisation of the hypothalamic-pituitary-gonadal (HPG) axis. Our laboratory delivers a comprehensive, multi-analyte sex hormone panel using isotope-dilution liquid chromatography-tandem mass spectrometry (LC-MS/MS) as the reference method, complemented by high-sensitivity chemiluminescence and advanced kinetic modelling, to offer an unparalleled depth of insight into reproductive and metabolic health.

The Clinical Rationale for High-Resolution Sex Hormone Profiling

Routine measurement of total testosterone (TT) and oestradiol (E2) by direct immunoassay is known to be unreliable at low concentrations, particularly in women, children, and hypogonadal men, where values approach the lower limit of quantification. Furthermore, total hormone levels do not reflect the biologically active fraction, which is determined by sex hormone-binding globulin (SHBG) and albumin. Our standard extended panel includes total oestradiol (E2), total testosterone (TT), free testosterone (calculated and by equilibrium dialysis), SHBG, progesterone, 17-hydroxyprogesterone (17-OHP), dehydroepiandrosterone-sulfate (DHEA-S), and androstenedione, along with the gonadotrophins follicle-stimulating hormone (FSH) and luteinising hormone (LH), measured by ultrasensitive immunoassay with traceability to WHO international standards. For fertility assessment, we also offer anti-Müllerian hormone (AMH) and inhibin B as markers of ovarian reserve and spermatogenesis. This integrated panel provides a complete endocrine snapshot, enabling the differentiation of primary from secondary gonadal failure, the evaluation of hirsutism and polycystic ovary syndrome (PCOS), the monitoring of gender-affirming hormone therapy, and the assessment of menopausal status and hormone replacement therapy (HRT) efficacy.

Our Analytical Capabilities: Reference-Method Accuracy and Metabolomic Depth

Our primary analytical workhorse for steroid hormones is a high-performance LC-MS/MS system equipped with a heated electrospray ionisation (HESI) source and a triple-quadrupole mass analyser, operating in multiple reaction monitoring (MRM) mode. We have developed and validated a single, comprehensive method for the simultaneous quantification of E2, TT, progesterone, 17-OHP, androstenedione, and DHEA-S in a 200-µL serum sample, with a run time of 8 minutes. Our limits of quantification (LOQs) are: E2 at 2 pg/mL, TT at 1 ng/dL, progesterone at 0.05 ng/mL, and DHEA-S at 0.5 µg/dL, which are substantially lower than immunoassay equivalents and permit accurate measurement in paediatric, female, and castrate-level samples. Inter-assay precision (CV) is consistently below 6% for all analytes, and we achieve complete chromatographic resolution of the isobaric compounds (e.g., testosterone and epitestosterone, androstenedione and androstanedione), eliminating cross-reactivity. For free testosterone, we offer both the calculated free testosterone (using Vermeulen's formula with SHBG and albumin) and the direct equilibrium dialysis method, which is considered the gold standard and is available upon request for complex cases.

Beyond the core panel, we provide dynamic functional tests, including standardised gonadotrophin-releasing hormone (GnRH) stimulation tests (with measurement of LH and FSH at timed intervals), human chorionic gonadotrophin (hCG) stimulation for Leydig cell reserve, and clomiphene citrate challenge for hypothalamic-pituitary axis integrity. These are interpreted with reference to our large normative database stratified by age, sex, menstrual cycle phase, and menopausal status. For research applications, we have developed a high-resolution UPLC-MS/MS method for the quantification of 15 steroid metabolites, including the backdoor androgen pathway intermediates (e.g., 11-ketotestosterone, 11β-hydroxyandrostenedione), which are increasingly recognised for their role in androgenetic alopecia and PCOS. We also offer salivary hormone testing for E2, progesterone, testosterone, and cortisol, validated against serum LC-MS/MS, suitable for circadian rhythm studies and at-home collection protocols.

Regulatory Compliance and Quality Assurance

All our sex hormone testing services are conducted under CLIA '88 and CAP accreditation, with methods validated in accordance with the FDA Guidance for Bioanalytical Method Validation. We participate in the CDC Hormone Standardization Program (HoSt) for testosterone and oestradiol, ensuring our results are directly traceable to reference methods and fully commutability with international standards. Each analytical run includes a nine-point calibration curve, six levels of quality controls (including low-level female/pediatric controls), and patient blanks. We rigorously assess matrix effects by post-column infusion and use isotopically labelled internal standards for every analyte to correct for recovery and ion suppression. Our reporting includes a detailed uncertainty budget and a flag for any sample with potential interference (e.g., heterophilic antibodies, biotin, or haemolysis) based on our dilutional linearity and recovery validation. Furthermore, we provide comprehensive interpretive reports that include cycle-phase adjusted reference intervals, gonadotrophin-to-hormone ratios, and a visual graph comparing the patient's profile to age-matched and sex-matched reference populations, facilitating immediate clinical interpretation.

Our Competitive Advantages in Sex Hormone Diagnostics

Our laboratory stands apart through several key differentiators that directly address the limitations of conventional testing. First, our use of LC-MS/MS for all steroid hormones eliminates the well-documented issues of immunoassay cross-reactivity, especially relevant for patients on oral contraceptives, HRT, or herbal supplements that can interfere with antibody-based methods. Second, we offer a complete one-stop panel that includes both steroid hormones and gonadotrophins, plus SHBG and albumin, allowing for a comprehensive HPG axis assessment from a single blood draw, reducing patient inconvenience and cost.

Third, our dynamic testing options, including hCG and GnRH stimulation protocols, are performed under medical supervision with pharmacokinetic modelling, and we provide the raw data and calculated indices (e.g., AUC, peak response, and response ratio) to aid in the differentiation of partial vs. complete deficiencies. Fourth, we provide advanced data integration with our proprietary algorithms that automatically calculate the free androgen index (FAI), the E2/testosterone ratio, and the LH/FSH ratio, while also flagging results consistent with PCOS (using the Rotterdam criteria), hypogonadotropic hypogonadism, or hyperprolactinaemia (with optional prolactin measurement). All reports are available in a secure electronic portal with trend visualisation for longitudinal monitoring—critical for patients undergoing puberty induction, fertility treatment, or cancer survivorship follow-up.

Fifth, our expert team includes board-certified reproductive endocrinologists and clinical chemists who are available for direct consultation on complex case interpretation, including atypical hormone profiles, assay discordances, and therapeutic drug monitoring (e.g., testosterone esters in hypogonadal men). We also offer customised panels for pharmaceutical clinical trials, including full method validation reports, stability data, and cross-validation to legacy immunoassays, ensuring seamless data comparability across study phases.

Specimen Types and Clinical Applications

Our sex hormone testing is validated on serum, plasma (heparin, EDTA), and, for selected analytes, on dried blood spots (DBS) and saliva—with detailed instructions for collection and shipping to maintain stability. Clinical applications encompass a wide spectrum: evaluation of delayed or precocious puberty, workup of infertility in both sexes, diagnosis and management of PCOS and hyperandrogenism, monitoring of testosterone replacement therapy, assessment of menopausal status and bone health, screening for hormone-sensitive cancers (breast, prostate), and follow-up of transgender individuals on gender-affirming hormone regimens. Our service also supports obstetric practice through second-trimester screening for placental function using oestriol and inhibin A, and we provide rapid STAT testing for suspected acute adrenal insufficiency with 17-OHP and cortisol.

Innovation and Research Partnerships

We are at the forefront of developing novel biomarkers in reproductive endocrinology. Our current research focuses on ultra-sensitive E2 assays for aromatase inhibitor therapy monitoring in breast cancer, and the use of machine learning to predict ovarian response to stimulation in IVF based on baseline AMH, antral follicle count, and hormonal ratios. We also collaborate with academic centres to establish reference intervals for the emerging 11‑oxygenated androgens across the lifespan. Our findings are regularly published in journals such as the Journal of Clinical Endocrinology & Metabolism and Clinical Chemistry, ensuring our testing menu remains evidence-based and state-of-the-art.

Client Engagement and Service Model

We prioritise a seamless experience from test ordering to result delivery. Clients receive free collection kits with stabilising tubes, pre-labelled shipping materials, and clear instructions for sample handling. Our standard turnaround time for the full steroid panel is 48 hours, with a 24-hour rapid service for urgent clinical decisions. All reports are delivered via a secure online portal with push notifications and integration options for electronic medical records. For high-volume centres and clinical trial sponsors, we offer dedicated project managers, customised report formats, and batch statistical summaries. Our pricing is transparent and competitive, with volume discounts and flexible billing options. We also provide free educational webinars and case-based discussions to help clinicians maximise the utility of advanced sex hormone testing in their practice.

Conclusion: Redefining Sex Hormone Assessment as a Precision Diagnostic Tool

Sex hormone testing, when performed with the analytical rigour of isotope-dilution mass spectrometry, comprehensive panel inclusion, and dynamic functional interpretation, evolves from a rudimentary screening tool into a precision diagnostic instrument capable of unravelling complex endocrine conditions. Our laboratory delivers this integrated solution—combining reference-method accuracy, broad analyte coverage, kinetic testing options, and expert clinical interpretation—to empower clinicians with the actionable data needed for personalised patient management. Whether the clinical question involves fertility, menopause, androgen deficiency, or transgender health, our services provide the depth and reliability essential for confident decision-making.

We welcome you to partner with us for your sex hormone testing needs. Our team of endocrinologists and laboratory scientists is ready to assist with test selection, result interpretation, and follow-up recommendations. By choosing our laboratory, you gain a dedicated ally in reproductive and metabolic health, underpinned by innovation, quality, and an unwavering commitment to patient-centric care.